Pathobiological Sciences
Jerome Harms has not added Biography.
If you are Jerome Harms and would like to personalize this page please email our Author Liaison for assistance.
Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene.
Journal of medical microbiology Jan, 2002 | Pubmed ID: 11803949
Encephalomyocarditis and Mengo viruses productively infect murine T-lymphocyte cell lines but not fresh ex vivo derived T lymphocytes.
Viral immunology , 2002 | Pubmed ID: 11952137
Enhanced efficacy of DNA vaccines against an intracellular bacterial pathogen by genetic adjuvants.
Current pharmaceutical biotechnology Apr, 2003 | Pubmed ID: 12678885
Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22.
Journal of virology Apr, 2004 | Pubmed ID: 15047837
Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.
Genetic vaccines and therapy Aug, 2004 | Pubmed ID: 15327692
The role of integrase/recombinase xerD and monofunctional biosynthesis peptidoglycan transglycosylase genes in the pathogenicity of Brucella abortus infection in vitro and in vivo.
Microbial pathogenesis Nov, 2004 | Pubmed ID: 15519045
Bovine herpesvirus VP22 induces apoptosis in neuroblastoma cells by upregulating the expression ratio of Bax to Bcl-2.
Human gene therapy Jan, 2005 | Pubmed ID: 15703493
Brucella: functional genomics and host-pathogen interactions.
Animal health research reviews / Conference of Research Workers in Animal Diseases Jun-Dec, 2006 | Pubmed ID: 17389050
TBK1 does not play a role in the control of in vitro Burkholderia pseudomallei growth.
Transactions of the Royal Society of Tropical Medicine and Hygiene Dec, 2008 | Pubmed ID: 19121697
Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.
Journal of immune based therapies and vaccines , 2009 | Pubmed ID: 19126207
Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP.
The Journal of biological chemistry Apr, 2009 | Pubmed ID: 19196716
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
Infection and immunity Jan, 2010 | Pubmed ID: 19884330
Modulation of microtubule dynamics by a TIR domain protein from the intracellular pathogen Brucella melitensis.
The Biochemical journal Oct, 2011 | Pubmed ID: 21692747
Brucella melitensis cyclic di-GMP phosphodiesterase BpdA controls expression of flagellar genes.
Journal of bacteriology Oct, 2011 | Pubmed ID: 21856843
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。